For women of childbearing potential, these medications are not recommended during pregnancy or breastfeeding, and discontinuation is advised at least 2 months before planned pregnancy for semaglutide and 1 month for tirzepatide
Specifically, the FDAs decision not to include these GLP-1s on the bulk compounding list would not be expected to affect their use by 503A pharmacies
Consistency matters more than volume
In some cases, companies are signing deals to secure exclusive rights to a particular drug with an upfront payment, followed by a series of additional investments linked to development, regulatory and sales milestones
This waiver allows providers to prescribe Schedule III-V medications like phentermine to new telehealth patients without a prior physical exam
Scientific interest in 5-Amino-1MQ often centers on its relationship to nicotinamide N-methyltransferase research and metabolic pathway investigation